The shares of pharmaceutical companies are seen up amid volatility in the broad market next week, dealers said today. Ranbaxy is likely to rise further next week, with resistance at Rs 530. GlaxoSmithKline Pharmaceuticals is trying to breach the Rs 1,140 level, but may face selling pressure.
Cadila Pharma is seen range-bound, while Cipla’s pattern on the charts indicates that the stock is set for an upside, with a resistance at Rs 243.
IT stocks are seen moving in a range of 1-5 per cent because of the hazy business environment scenario.
Cognizant Technology Solutions cut its full-year earnings outlook on Thursday. This is not being viewed as a major negative for the Indian IT sector, but a confirmation of the uncertain business environment, an analyst said.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app